Tilray Brands welcomed the Luxembourg Ministry of Health Delegation to the company’s European campus and facility located in Cantanhede, Portugal. Tilray’s EU-GMP-certified medical cannabis cultivation and manufacturing facility in Portugal provides patients in Luxembourg and across Europe, where permitted by law, with safe and reliable access to high-quality medical cannabis.
The visit was organized to give the Luxembourg Delegation a firsthand view of Tilray’s EU-GMP operations in Portugal, the premier medical cannabis site in Europe. The delegation included:
- Paulette Lenert, Deputy Prime Minister and Minister of Health of Luxembourg.
- H. E. Conrad Bruch, Ambassador of Luxembourg to Portugal.
- Alain Origer, National Drugs Coordinator.
- Laura Valli, International Affairs Coordinator.
- Bob Lessel, Social Health Department.
- Sven Back, Department of narcotics and medicinal cannabis.
Sascha Mielcarek, Tilray’s Managing Director in Europe, said, “We are honored to host the Luxembourg Ministry of Health Delegation at our state-of-the-art cannabis facility in Cantanhede, Portugal. Demand for cannabis legalization in Europe is growing rapidly, and we are incredibly proud to service the patients in Luxembourg and around the world with the high-quality medical cannabis products they rely on and in the formats they prefer.”
Tilray has a pioneering track record as a company committed to producing the highest-quality cannabis products available to consumers and patients in need around the world and was the first to successfully export medical cannabis from North America and import medical cannabis products into the EU in 2016.
For more information: